Call for Applications: Deadline Extended to May 31, 2022
The Connecticut Convergence Institute has been awarded the T32 Program Grant Regenerative Engineering of Musculoskeletal Tissues: A Convergence Doctoral Training Program by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, AR079114). This T32 Program aims to educate, support and enhance the training of individuals dedicated to careers as independent translational and basic scientists in regenerative engineering. The program offers inter-disciplinary research training at UConn Health and UConn Storrs combining the fields of biomedical science and engineering.
Trainees will be selected from current UConn graduate students at UConn Health and UConn Storrs who have completed their first year of graduate studies. The T32 Program will offer trainees a broad level of expertise in research and instruction based on the research and educational experiences of the biomedical and engineering faculty who serve as preceptors. Trainees will become experts in regenerative engineering and its foundations to work towards the alleviation of human disease and musculoskeletal injuries by means of tissue regeneration. The Program strengths include its interdisciplinary and collaborative research in biomedical science and engineering, interactions with diverse trainees and faculty, training in contemporary research methodologies, and experienced preceptors.
All applicants must:
- Be a citizen or Permanent Resident of the United States.
- Be current UConn Health or UConn Storrs graduate student who has completed their first year of PhD studies.
- Demonstrate high motivation and potential to become a basic, clinical or translational scientist with an interest in the field of Regeneration.
- Have a high probability of fulfilling the educational goals of this program.
Submission Deadline: May 31, 2022
- Individuals will request an application package directly by email to Lana Angelo at firstname.lastname@example.org.
- Application Documents
- NIH Fellowship Biosketch: Use the most current Fellowship Biosketch format (Rev. 10/2021 Approved Through 09/30/2024) and follow the Instructions for a Biographical Sketch. This is the key document to be used for this application. *Failure to complete all sections of the biosketch will result in disqualification.
- Letter(s) of Recommendation: A Letter of Recommendation is required from the current UConn Health or UConn Storrs faculty member with whom the applicant has worked closely in their first year of doctoral program research. A recommendation from a lab rotation mentor, major advisor, or advisory committee member is suggested.
- Applicants will submit their application package directly by email to Lana Angelo at email@example.com.
Current T32 Scholars
Godwin is a graduate student at the University of Connecticut – Department of Chemical and Biomolecular engineering. His research study focuses on regeneration of articular cartilage in treating osteoarthritis. Since 2018, he has been part of the Connecticut Convergence Institute of Translation in Regenerative Engineering.
His work seeks a convergence approach to the treatment of osteoarthritis and other musculoskeletal diseases by employing multi-disciplinary approach the foster mechanistic regenerative applications. This mechanistic regenerative perspective is evident in applications of bioengineering approaches involving cells and developmental control. Revealing that, mechanical stresses induces cytoskeletal tension-dependent changes that alter the extracellular matrix compliance and function.
Jacob Quint is a Ph.D. student and graduate research trainee in biomedical engineering at the University of Connecticut Health Center. He received his MS and BS in mechanical engineering at the University of Nebraska. He is a recipient of the T32 Regenerative Engineering of Musculoskeletal Tissues fellowship to generate solutions to alleviate human disease and musculoskeletal injuries by means of tissue engineering. His research focuses on creating translational technologies and techniques for regenerating skeletal muscle and other soft tissues. He has developed novel scaffolds for the treatment of skeletal muscle injuries using nanoparticles to control the biological and mechanical environment of the wound. He has also engineered a handheld device for the in vivo delivery of biomimetic scaffolds to leverage the power of the human body as a bioreactor and streamline regulatory hurdles. He works under the guidance of Dr. Ali Tamayol in his Laboratory for Innovative Microtechnologies & Biomechanics (LIMB). Jacob has participated in several entrepreneurial activities and incubator programs at both the University of Nebraska and the University of Connecticut. He has been awarded over $21,000 in prizes and awards from these programs and pitch competitions. He is active in developing a portfolio of intellectual property in the form of patents from his research in the hopes of generating commercially viable medical solutions and treatment modalities that will be utilized in improving real patient care.